Consultancy & Advisory

Biomedical AI consultancy, model audit, and regulatory-facing evidence support

I help biomedical, pharma, MedTech, digital health, and clinical research teams build, validate, audit, and repair AI/ML pipelines for diagnostic/prognostic models, biomarkers, MLE-NITs, SaMD, SaaS clinical AI, LLM-based decision support, and on-device medical AI.

Primary commercial focus

Independent audit of medical AI systems

The most focused consultancy offer is independent AI/ML model audit and regulatory-facing evidence support: leakage, confounding, validation design, calibration, subgroup behavior, reproducibility, XAI, deployment assumptions, and lifecycle risks.

Open dedicated audit page

What I can help with

Medical AI model audit

Independent technical review of SaMD, SaaS clinical AI, diagnostic/prognostic models, LLM/RAG systems, and on-device medical AI.

ML pipeline forensics

Leakage, cohort effects, batch effects, confounding, overfitting, split design, thresholding, and reproducibility checks.

Regulatory-facing evidence

Scientific and technical support around validation, transparency, model documentation, intended-use alignment, and lifecycle risk thinking.

Investor / VC technical due diligence

Independent review of medical AI startup claims, validation evidence, scientific credibility, deployment assumptions, and regulatory-facing gaps before investment decisions.

Biomedical AI development

Models for diagnosis, prognosis, biomarkers, imaging, omics, tabular clinical data, and clinical decision support.

MLE-NITs

Machine-learning-enhanced non-invasive tests: compact, interpretable upgrades to clinical scores and biomarker panels.

XAI & feature selection

Biomarker prioritization, biological signal retrieval, and potential drug-target identification for pharma-relevant discovery.

Low-data model design

ZACH-ViT, hZACH-ViT, s-DNNs, and compact baselines that can be trained and audited without massive compute.

LLMs & multimodal AI

RAG, clinical decision-support prototypes, drug-safety workflows, and multimodal pipelines combining text, imaging, omics, and structured data.

Angel investors, venture capital, family offices, corporate innovation

Medical AI technical due diligence

I can support investment teams evaluating medical AI, SaMD, digital health, biomarker, clinical decision-support, and on-device AI companies. The goal is to independently assess whether the company's AI claims are technically credible, clinically meaningful, reproducible, bias-aware, and supported by evidence that matches the intended use.

Typical checks include data provenance, validation design, patient/site leakage, external validation, calibration, subgroup performance, explainability, deployment assumptions, regulatory-facing evidence gaps, and the realism of the startup's claimed performance.

View investor diligence service

Domain experience

  • Biomedical AI: liver disease, MASLD/MASH, fibrosis, steatosis, AML, periodontitis, drug interactions, adverse drug reactions.
  • Medical imaging: ultrasound, B-mode imaging, lung ultrasound, liver ultrasound, breast-lesion risk prediction, segmentation/classification.
  • Biomarkers and omics: proteomics, transcriptomics, extracellular vesicles, multimodal clinical data, and feature selection.
  • Biometrics and security: ECG authentication, face recognition, privacy-preserving biometrics, adversarial robustness.
  • Industrial data science: route planning, ETA prediction, TSP, geocoding, speed-profile imputation, computer vision, and production ML.

Typical deliverables

  • Technical audit reports and methodology review documents.
  • Reproducible Python notebooks and ML pipelines.
  • Model validation reports with metrics, confidence intervals, calibration, and bias/confounding analysis.
  • Feature-selection and explainability reports.
  • Prototype models, proof-of-concept systems, and production-readiness recommendations.
  • Scientific manuscript support for ML methodology and reporting.
  • Investor / VC technical due diligence memo for medical AI startup evaluation.

Why work with me?

I combine mathematical/statistical methodology, biomedical AI research, high-stakes model validation, explainable AI, and production data science experience across Amsterdam UMC, Diagnostic Echotomography, MGH/Harvard, Huawei, Plotwise, and independent biomedical AI consultancy.

Useful when a project needs rigorous validation, reproducible code, clear interpretation, and defensible technical documentation.

Consultancy focus areas

Medical AI AuditSaMDSaaS Clinical AIOn-Device AIRegulatory-Facing EvidenceInvestor Due DiligenceVC Technical ReviewBiomedical AIClinical MLExplainable AIFeature SelectionModel ValidationML Pipeline ForensicsMLE-NITsDiagnostic Test ValidationPrognostic ModelingBiomarker DiscoveryBias AssessmentConfoundingData-Centric AISynthetic DataMedical ImagingOmicsLLMsRAGBiometricsLow-Data AITrain-from-Scratch Models

Scope note

Scientific and technical support

I provide scientific, statistical, and machine-learning evidence support for regulatory-facing, clinical, investor, and production-readiness decisions. This does not replace notified bodies, legal counsel, quality-management specialists, or regulatory affairs consultants.

Use this form for model audit, consultancy, seminars, or collaboration

Request a consultancy discussion

Briefly describe your organization, model/system, data modality, intended use, current validation stage, and timeline.

Available globally in English and Greek - online, onsite, or hybrid.

Contact

Discuss a project

For confidential or early-stage projects, send a short non-confidential summary first.

ath.angelakis@gmail.com